Webcasts & Presentations

Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

May 29, 2024

Neurocrine Biosciences to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

SAN DIEGO, May 29, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 45th Annual Global Healthcare Conference at 10:40 a.m. Eastern Time on Thursday June 13, 2024 in Miami. Kevin Gorman, Chief Executive Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the conference.

OPEN WEBCAST

May 29, 2024

Neurocrine Biosciences to Present at the Jefferies Global Healthcare Conference

SAN DIEGO, May 29, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Jefferies Global Healthcare Conference at 2:30 p.m. Eastern Time on Wednesday June 5, 2024 in New York. Kevin Gorman, Chief Executive Officer, Kyle Gano, Chief Business Development and Strategy Officer, and Matt Abernethy, Chief Financial Officer, will present at the conference.

OPEN WEBCAST

May 7, 2024

Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference

SAN DIEGO, May 7, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the BofA Securities 2024 Health Care Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday May 14, 2024 in Las Vegas. Kevin Gorman, Chief Executive Officer, Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the conference.

OPEN WEBCAST